BCL2 and diffuse large B-cell lymphoma: From an immunohistochemical point of view, DLBCL constantly expresses B-associated antigens and, in approximately 50% of cases, shows overexpression of the anti-apoptotic protein BCL2: this anomaly has a negative prognostic significance due to the higher incidence of relapses as well as the lower response to therapy.